Ex-SAC Manager Had Early Read On Study, Court Hears

Law360, New York (January 15, 2014, 6:36 PM EST) -- A medical researcher testified Wednesday that ex-SAC Capital Advisors LP portfolio manager Mathew Martoma seemed to know the results of a key Alzheimer's disease study before they were released, an account that bolsters the government's insider trading case.

Researcher Joel Ross, who helped test the experimental drug bapineuzumab, said that Martoma seemed to have an early read on trial results to be presented at a July 29, 2008, conference.

"He seemed quite familiar with the slides," Ross said in his second day of testimony.

Prosecutors allege...
To view the full article, register now.